Skip to main content

Table 4 HMG-CoAR binding site residues involved in docking interactions with pravastatin and dipeptides, with docking scores

From: Inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase enzyme by dipeptides identified in dry-cured ham

Pravastatin

Binding energy (kcal/mol)

Inhibition constant

Protein residues involved in H-bond interactions (chain:residue)

No. of H bonds

Protein residues involved in hydrophobic interactions (chain:residue)

Protein residues involved in salt bridges (chain:residue)

AA

−10.13

37,85 (nM)

C:Ser684 (Donor,sd)

C:Asp690 (Acceptor)

C:Asp690 (Acceptor)

C:Asp690 (Donor)

C:Lys691 (Donor,sd)

C:Lys692 (Donor,sd)

D:Glu559 (Acceptor,sd)

D:Asn755 (Donor,sd)

8

C:Asn658

C:Lys662

D:His752

D:Leu853

D:Leu862

D:Leu862

D:Val863

D:Val863

C:Arg590 (Carboxilate)

C:Lys692 (Carboxilate)

D:Lys735 (Carboxilate)

AL

−6.47

18.03 (μM)

C:Ser684 (Donor,sd)

C:Lys691 (Donor,sd)

D:Glu559 (Acceptor,sd)

D:Ala751 (Acceptor)

D:Asn755 (Donor,sd)

5

D:His752

D:Leu853

D:Leu862

C:Arg590 (Carboxilate)

C:Lys692 (Carboxilate)

D:Lys735 (Carboxilate)

AQ

−6.41

20.08 (μM)

C:Asp690 (Acceptor,sd)

D:Glu559 (Acceptor,sd)

D:Glu559 (Acceptor,sd)

D:His752 (Donor,sd)

D:Asn755 (Donor,sd)

5

C:Asp690

C:Lys691

D:His752

C:Arg590 (Carboxilate)

DA

−6.58

15.08 (μM)

C:Asn658 (Acceptor,sd)

C:Asn658 (Acceptor,sd)

C:Ser661 (Donor,sd)

C:Lys662 (Donor,sd)

D:Gly560 (Acceptor)

D:Leu862 (Acceptor)

6

D:Glu559

D:Val863

C:Arg590 (Carboxilate)

DD

−6.92

8.51 (μM)

C:Ser684 (Donor,sd)

C:Asp690 (Acceptor,sd)

D:Glu559 (Acceptor,sd)

D:Glu559 (Acceptor,sd)

D:Ala751 (Acceptor)

D:Asn755 (Donor,sd)

6

C:Lys691

D:His752

C:Arg590 (Carboxilate)

C:Lys691 (Carboxilate)

C:Lys692 (Carboxilate)

D:Lys735 (Carboxilate)

EE

−7.03

7.03 (μM)

C:Arg590 (Donor,sd)

C:Arg590 (Donor,sd)

C:Ser661 (Donor,sd)

C:Ser684 (Donor,sd)

C:Asp690 (Acceptor,sd)

C:Lys691 (Donor,sd)

D:Glu559 (Acceptor,sd)

D:Ala751 (Acceptor)

8

D:Leu853

C:Arg590 (Carboxilate)

C:Arg590 (Carboxilate)

C:Lys692 (Carboxilate)

C:Lys692 (Carboxilate)

D:Lys735 (Carboxilate)

ES

−8.52

569.34 (nM)

C:Asn658 (Donor,sd)

C:Ser661 (Donor,sd)

C:Ser684 (Donor,sd)

D:Glu559 (Acceptor,sd)

D:Glu559 (Acceptor,sd

D:Asn755 (Donor,sd)

6

D:Leu853

C:Arg590 (Carboxilate)

C:Arg590 (Carboxilate)

C:Lys691 (Carboxilate)

C:Lys692 (Carboxilate)

D:Lys735 (Carboxilate)

D:Lys752 (Carboxilate)

LL

−6.83

9.85 (μM)

C:Arg590 (Donor,sd)

C:Asn658 (Acceptor,sd)

C:Ser661 (Donor,sd)

C:Ser684 (Donor,sd)

C:Lys691 (Donor,sd)

C:Lys692 (Donor,sd)

D:Ala751 (Acceptor,sd)

D:Ala751 (Acceptor,sd)

D:Asn755 (Donor,sd)

9

D:Leu862

C:Arg590 (Carboxilate)

C:Arg590 (Carboxilate)

C:Lys692 (Carboxilate)

D:Lys735 (Carboxilate)

QQ

−6.69

12.46 (μM)

C:Asp690 (Acceptor,sd)

D:Glu559 (Acceptor,sd)

D:Glu559 (Acceptor,sd)

D:His752 (Donor,sd)

D:Asn755 (Donor,sd)

5

C:Lys691

D:His752

C:Arg590 (Carboxilate)

VH

−5.91

46.66 (μM)

C:Arg590 (Donor,sd)

C:Ser684 (Donor,sd)

C:Asp690 (Acceptor)

C:Asp690 (Acceptor,sd)

C:Lys692 (Donor,sd)

D:Gly560 (Acceptor)

D:Ser565 (Acceptor,sd)

D:Ser565 (Donor,sd)

D:Lys735 (Donor,sd)

D:His752 (Donor,sd)

D:Asn755 (Donor.sd)

11

D:Leu853

C:Lys691 (Carboxilate)

Ligand

−6.53

16.3 (μM)

C:Arg590 (Donor,sd)

C:Asn658 (Acceptor,sd)

C:Asn658 (Acceptor,sd)

C:Asn658 (Donor,sd)

C:Ser661 (Donor,sd)

C:Lys691 (Donot,sd)

D:Glu559 (Acceptor,sd)

D:Gly560 (Acceptor)

8

 

C:Arg590 (Carboxilate)

  1. Key residues of the binding site are highlighted in bold. Common residues whereby pravastatin and dipeptides interact with are coloured in purple